tetano
Editor, Senior Moderator
Braz Oral Res
. 2020;34:e048.
doi: 10.1590/1807-3107bor-2020.vol34.0048. Epub 2020 May 15.
Immunocompromised Patients and Coronavirus Disease 2019: A Review and Recommendations for Dental Health Care
Roberta Rayra Martins-Chaves[SUP] 1 [/SUP], Carolina Cavali?ri Gomes[SUP] 2 [/SUP], Ricardo Santiago Gomez[SUP] 1 [/SUP]
Affiliations
Abstract
In less than four months, an unprecedented pandemic changed the world scenario, closing institutions and commerce, paralyzing sports championships, blocking frontiers, and putting almost all populations in a house quarantine regimen. Immunocompromised patients are within the high-risk group to severe outcomes from COVID-19. However, there is no clear evidence of the association between impaired immune host status and complications from SARS-CoV-2 infection so far. The virus is transmitted by inhalation or direct contact with infected secretions, and therefore the dental office is a highly susceptible environment for such transmission. Here, we review the literature and discuss immunological COVID-19 related issues. We also make suggestions for immunocompromised patients' support in this new emerging context of clinical dental practice. Until comprehensive findings are published, individuals with impaired immunity should be considered as high-risk. Cross infection control procedures for the clinical care of immunocompromised patients should follow the same guidelines that are being proposed for immunocompetent ones. However, during the active outbreak, people under immunosuppressive conditions should not receive elective procedures, even if they do not have symptoms or exposure history to COVID-19, and in case of emergence, care must be done in a separate airborne room. In the pos-pandemic phase, the dental care general recommendations should be the same for all subjects. Changes in the current guidelines have been proposed to SARS-CoV-2 infection control in order to provide the best and safe dental practice. However, they still need to be validated by future studies.
. 2020;34:e048.
doi: 10.1590/1807-3107bor-2020.vol34.0048. Epub 2020 May 15.
Immunocompromised Patients and Coronavirus Disease 2019: A Review and Recommendations for Dental Health Care
Roberta Rayra Martins-Chaves[SUP] 1 [/SUP], Carolina Cavali?ri Gomes[SUP] 2 [/SUP], Ricardo Santiago Gomez[SUP] 1 [/SUP]
Affiliations
- PMID: 32428085
- DOI: 10.1590/1807-3107bor-2020.vol34.0048
Abstract
In less than four months, an unprecedented pandemic changed the world scenario, closing institutions and commerce, paralyzing sports championships, blocking frontiers, and putting almost all populations in a house quarantine regimen. Immunocompromised patients are within the high-risk group to severe outcomes from COVID-19. However, there is no clear evidence of the association between impaired immune host status and complications from SARS-CoV-2 infection so far. The virus is transmitted by inhalation or direct contact with infected secretions, and therefore the dental office is a highly susceptible environment for such transmission. Here, we review the literature and discuss immunological COVID-19 related issues. We also make suggestions for immunocompromised patients' support in this new emerging context of clinical dental practice. Until comprehensive findings are published, individuals with impaired immunity should be considered as high-risk. Cross infection control procedures for the clinical care of immunocompromised patients should follow the same guidelines that are being proposed for immunocompetent ones. However, during the active outbreak, people under immunosuppressive conditions should not receive elective procedures, even if they do not have symptoms or exposure history to COVID-19, and in case of emergence, care must be done in a separate airborne room. In the pos-pandemic phase, the dental care general recommendations should be the same for all subjects. Changes in the current guidelines have been proposed to SARS-CoV-2 infection control in order to provide the best and safe dental practice. However, they still need to be validated by future studies.